@article{d121a8493a544e37bc7ea877fa352d59,
title = "Preclinical combination of TP-0903, an AXL inhibitor and B-PAC-1, a procaspase-activating compound with ibrutinib in chronic lymphocytic leukemia",
author = "Viralkumar Patel and Keating, \{Michael J.\} and Wierda, \{William G.\} and Varsha Gandhi",
note = "Funding Information: This work was supported in part by grant P01CA81534 from the NCI, DHHS, sponsored research agreements from Pharmacyclics and Vanquish, and funds from the MD Anderson Moon Shot Program.",
year = "2016",
month = jun,
day = "2",
doi = "10.3109/10428194.2015.1102243",
language = "English (US)",
volume = "57",
pages = "1494--1497",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor and Francis Ltd.",
number = "6",
}